{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T13:51:12Z","timestamp":1776693072599,"version":"3.51.2"},"reference-count":15,"publisher":"European Respiratory Society (ERS)","issue":"1","content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2018,4,13]]},"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1183\/13993003.00395-2018","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T15:40:12Z","timestamp":1525966812000},"page":"1800395","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["3-month daily rifampicin and isoniazid compared to 6- or 9-month isoniazid for treating latent tuberculosis infection in children and adolescents less than 15 years of age: an updated systematic review"],"prefix":"10.1183","volume":"52","author":[{"given":"Yibeltal","family":"Assefa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yalemzewod","family":"Assefa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solomon","family":"Woldeyohannes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohhei","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haileyesus","family":"Getahun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"81","published-online":{"date-parts":[[2018,5,10]]},"reference":[{"key":"2024102100265180000_52.1.1800395.1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002152"},{"key":"2024102100265180000_52.1.1800395.2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01245-2015"},{"key":"2024102100265180000_52.1.1800395.3","unstructured":"World Health Organization. The End TB Strategy. Global strategy and targets for tuberculosis prevention, care and control after 2015. Geneva, WHO, 2014."},{"key":"2024102100265180000_52.1.1800395.4","unstructured":"World Health Organization. Recommendations for investigating contacts of persons with infectious tuberculosis in low-and middle-income countries. Geneva, WHO, 2012."},{"key":"2024102100265180000_52.1.1800395.5","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)30216-X"},{"key":"2024102100265180000_52.1.1800395.6","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2013-303876"},{"key":"2024102100265180000_52.1.1800395.7","unstructured":"World Health Organization. New fixed-dose combinations for the treatment of TB in children. Geneva, WHO, 2016."},{"key":"2024102100265180000_52.1.1800395.8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097"},{"key":"2024102100265180000_52.1.1800395.9","doi-asserted-by":"crossref","first-page":"960","DOI":"10.3390\/ijms17060960","article-title":"Pediatric tuberculosis in Italian children: epidemiological and clinical data from the Italian register of pediatric tuberculosis","volume":"17","author":"Galli","year":"2016","journal-title":"Int J Mol Sci"},{"key":"2024102100265180000_52.1.1800395.10","doi-asserted-by":"publisher","DOI":"10.1086\/520983"},{"key":"2024102100265180000_52.1.1800395.11","first-page":"13","article-title":"Adherence to anti-tuberculosis chemoprophylaxis and treatment in children","volume":"10","author":"Van Zyl","year":"2006","journal-title":"Int J Tubercul Lung Dis"},{"key":"2024102100265180000_52.1.1800395.12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/adc.78.2.169","article-title":"Rifampicin and isoniazid prophylactic chemotherapy for tuberculosis","volume":"78","author":"Ormerod","year":"1998","journal-title":"Arch Dis Child"},{"key":"2024102100265180000_52.1.1800395.13","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2010.182600"},{"key":"2024102100265180000_52.1.1800395.14","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.5588\/ijtld.15.0908","article-title":"Rifampicin resistance after treatment for latent tuberculous infection: a systematic review and meta-analysis","volume":"20","author":"Den Boon","year":"2016","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024102100265180000_52.1.1800395.15","doi-asserted-by":"crossref","first-page":"248","DOI":"10.7326\/M17-0609","article-title":"Treatment of latent tuberculosis infection: an updated network meta-analysis","volume":"167","author":"Zenner","year":"2017","journal-title":"Ann Intern Med"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.00395-2018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T06:57:40Z","timestamp":1740380260000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.00395-2018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,10]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,7,11]]},"published-print":{"date-parts":[[2018,7]]}},"alternative-id":["10.1183\/13993003.00395-2018"],"URL":"https:\/\/doi.org\/10.1183\/13993003.00395-2018","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,10]]}}}